Individuals Discontinuing Slimming Injections Put On Weight Far More Rapidly Than Dieters

Illustration of medical syringe and weighing machine
Obesity treatment involves ongoing approaches.

Fresh analysis reveals that patients who come off blockbuster slimming jabs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who stop conventional lifestyle programs.

Published data in a major medical journal points out that while obese individuals often shed about a fifth of their body weight while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month after stopping.

"Individuals purchasing these drugs need to be aware of the danger of fast rebound weight gain when the medication ends," stated researcher Dr. Susan Jebb.

This pace of recovery means a reversion to pre-treatment weight within about one and a half years.

Weighing Approaches

The analysis, which looked at dozens of studies involving thousands of participants, compared the effects of GLP-1 agonists with conventional dieting.

Scientists emphasize that individuals who shed pounds through dieting generally see a slower weight regain—perhaps 100 grams monthly—post-intervention.

Understanding the Fast Rebound

Doctors suggest the mechanism of the drugs accounts for the heightened regain.

The injections copy a natural hormone called GLP-1, which helps regulate appetite.

"Sustained high doses of the hormone concentrations several times higher than normal may cause the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this GLP-1 'fix' results in appetite is uncontrolled, making overeating far more likely."

A Chronic Condition?

The NHS recommend the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians argue that, given the high risk of weight regain, the therapy might need to be ongoing.

This opinion is reinforced by drug manufacturers, who note that the findings "highlight the persistent character of excess weight," similar to managing diseases like high blood pressure.

User Accounts

Individuals who have come off the jabs report a powerful resurgence of cravings.

"It felt as if something activating and I was suddenly ravenous," described one woman.

The struggle is worsened if individuals have not established sustainable dietary or behavioural changes during therapy.

Significant Interest

Survey data show that millions of people in the UK have tried these injections in the past year, with desire remaining high.

  • Use is higher among females compared to males.
  • The middle-aged age group shows the highest usage rates.
  • A large proportion access the drugs through private healthcare rather than the NHS.

Finally, experts caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic cure and maintained weight loss relies on ongoing lifestyle support.

Clayton Baker
Clayton Baker

A seasoned gaming analyst with over a decade of experience in online casino reviews and player strategy development.